Phase I/II Study of Weekly Oral MTX + AZT in the Treatment of Metastatic Adenocarcinoma of the Pancreas and Hepatoma – GI91-1

Abstracts/Posters/Presentations:

• Mortimer J, Weber G, Fracasso P, Pletcher W, Ansari R. Phase I-II Study of Zidovudine (AZT) and Methotrexate (MTX) in Advanced Pancreatic Cancer and Hepatoma: A Hoosier Oncology Group and Walther Cancer Institute Trial GI91-1. Accepted to the ASCO Annual Meeting, May 14th – 17th, 1994, Dallas, Texas.

Manuscripts/Articles:

• Miller K, Loehrer PJ, Gonin R, Weber G, Ansari R, Pletcher W, McClean J, Spiridonidis CH, Mortimer J: Phase II Study of Weekly Oral Methotrexate and Zidovudine (AZT) in Advanced Adenocarcinoma of the Pancreas and Hepatocellular Carcinoma: Hoosier Oncology Group GI91-1. Invest New Drugs 14:207-212, 1996. See abstract.